TheraRadar
Data updated: May 26, 2026

PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE (phenylephrine hydrochloride)

Respiratory Approved 2009-08-25

PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE is indicated for the treatment of Upper Respiratory Symptoms; Nasal Congestion; Allergy; Common Cold.

Source: FDA Label • AMNEAL PHARMS
1
Indication
--
Phase 3 Trials
16
Years on Market

Details

Status
Prescription
First Approved
2009-08-25
Routes
ORAL
Dosage Forms
SYRUP

PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE Approval History

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
2 FDA actions from 2009 to 2015
May 2015 SUPPL
Label · Labeling
Aug 2009 ORIGINAL
Update

What PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE Treats

4 indications

PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE is approved for 4 conditions since its original approval in 2009. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Upper Respiratory Symptoms
  • Nasal Congestion
  • Allergy
  • Common Cold
Source: FDA Label

PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
CHLORPHENIRAMINE POLISTIREX
2 shared
TRIS PHARMA INC
Shared indications:
AllergyCommon Cold
KOVANAZE
OXYMETAZOLINE HYDROCHLORIDE
2 shared
ST RENATUS
Shared indications:
Nasal CongestionCommon Cold
PROMETHAZINE DM
DEXTROMETHORPHAN HYDROBROMIDE
2 shared
PAI HOLDINGS
Shared indications:
AllergyCommon Cold
📋

Clinical Trial Registry

2 trials
Trial Sponsor ID Phase Status Title
NCT05997732 STARS Pro00126600 Ph 4 recruiting Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences
NCT03098680 PRIME PRIME (A094136) Ph 1 terminated A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE FDA Label Details

Indications & Usage

PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE is indicated for the treatment of Upper Respiratory Symptoms; Nasal Congestion; Allergy; Common Cold.

Track PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.